Banque Pictet & Cie SA Raises Stake in Humana Inc. (NYSE:HUM)

Banque Pictet & Cie SA boosted its position in Humana Inc. (NYSE:HUM) by 114.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 37,541 shares of the insurance provider’s stock after purchasing an additional 20,031 shares during the quarter. Banque Pictet & Cie SA’s holdings in Humana were worth $9,525,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of HUM. State Street Corp increased its holdings in shares of Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock worth $1,701,582,000 after buying an additional 53,272 shares during the last quarter. FMR LLC raised its stake in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after buying an additional 643,291 shares in the last quarter. Pzena Investment Management LLC raised its position in shares of Humana by 8.1% in the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after acquiring an additional 187,903 shares in the last quarter. Ontario Teachers Pension Plan Board lifted its stake in shares of Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after purchasing an additional 71,910 shares during the period. Finally, Sanders Capital LLC boosted its position in shares of Humana by 1.0% during the third quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock valued at $370,060,000 after purchasing an additional 11,923 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price target on shares of Humana in a research report on Wednesday. TD Cowen raised their target price on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 target price on shares of Humana in a research report on Wednesday. Morgan Stanley dropped their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday. Finally, Wells Fargo & Company reduced their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average price target of $293.05.

Humana Trading Down 2.7 %

Shares of HUM opened at $252.92 on Friday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The company’s fifty day moving average is $272.44 and its 200 day moving average is $295.47. The stock has a market capitalization of $30.45 billion, a PE ratio of 22.40, a P/E/G ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. Sell-side analysts expect that Humana Inc. will post 16.11 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.